235 related articles for article (PubMed ID: 17558784)
1. Framework analysis for the carcinogenic mode of action of nitrobenzene.
Hsu CH; Stedeford T; Okochi-Takada E; Ushijima T; Noguchi H; Muro-Cacho C; Holder JW; Banasik M
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):155-84. PubMed ID: 17558784
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
3. Postulated carbon tetrachloride mode of action: a review.
Manibusan MK; Odin M; Eastmond DA
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(3):185-209. PubMed ID: 17763046
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
5. A critical review of the literature on nitrobenzene toxicity.
Beauchamp RO; Irons RD; Rickert DE; Couch DB; Hamm TE
Crit Rev Toxicol; 1982; 11(1):33-84. PubMed ID: 6761067
[TBL] [Abstract][Full Text] [Related]
6. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
Butterworth BE
Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
[TBL] [Abstract][Full Text] [Related]
7. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
Pfohl-Leszkowicz A; Manderville RA
Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic processes and cancer risk assessment.
Preston RJ
Mutat Res; 2007 Mar; 616(1-2):7-10. PubMed ID: 17147955
[TBL] [Abstract][Full Text] [Related]
9. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
10. U.S. EPA's IRIS assessment of 2-butoxyethanol: the relationship of noncancer to cancer effects.
Gift JS
Toxicol Lett; 2005 Mar; 156(1):163-78. PubMed ID: 15705494
[TBL] [Abstract][Full Text] [Related]
11. Nitrobenzene.
National Toxicology Program
Rep Carcinog; 2011; 12():294-6. PubMed ID: 21860498
[No Abstract] [Full Text] [Related]
12. Genotoxicity effect of nitrobenzene on soybean (Glycine max) root tip cells.
Guo D; Ma J; Li R; Guo C
J Hazard Mater; 2010 Jun; 178(1-3):1030-4. PubMed ID: 20303656
[TBL] [Abstract][Full Text] [Related]
13. 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.
Cohen SM; Boobis AR; Meek ME; Preston RJ; McGregor DB
Crit Rev Toxicol; 2006; 36(10):803-19. PubMed ID: 17118730
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the human relevance of chemically induced animal tumors.
Cohen SM; Klaunig J; Meek ME; Hill RN; Pastoor T; Lehman-McKeeman L; Bucher J; Longfellow DG; Seed J; Dellarco V; Fenner-Crisp P; Patton D
Toxicol Sci; 2004 Apr; 78(2):181-6. PubMed ID: 14737005
[TBL] [Abstract][Full Text] [Related]
15. Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge.
Anderson LM
Mutat Res; 2006 Sep; 608(2):136-56. PubMed ID: 16829162
[TBL] [Abstract][Full Text] [Related]
16. A strategy for the risk assessment of human genotoxic metabolites.
Dobo KL; Obach RS; Luffer-Atlas D; Bercu JP
Chem Res Toxicol; 2009 Feb; 22(2):348-56. PubMed ID: 19170655
[TBL] [Abstract][Full Text] [Related]
17. [Generalities about carcinogenesis].
Tubiana M
C R Biol; 2008 Feb; 331(2):114-25. PubMed ID: 18241804
[TBL] [Abstract][Full Text] [Related]
18. Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: A case study involving carbon tetrachloride.
Eastmond DA
Environ Mol Mutagen; 2008 Mar; 49(2):132-41. PubMed ID: 18213651
[TBL] [Abstract][Full Text] [Related]
19. Analysis of in vivo mutation data can inform cancer risk assessment.
Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action--naphthalene as an example.
Rhomberg LR; Bailey LA; Goodman JE
Crit Rev Toxicol; 2010 Sep; 40(8):671-96. PubMed ID: 20722583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
